Which hedge funds own HCAT? HEALTH CATALYST INC, Q2 2026 13F holders
Healthcare · Open on the interactive board
4 of the hedge funds tracked by WhaleCreep disclosed a position in HCAT (HEALTH CATALYST INC) in their Q2 2026 13F filings, worth $12.4m in total. The largest holder by portfolio weight is Palogic Value Management at 3.5% of its book. 2 managers opened a new position this quarter: Millennium Management, Citadel Advisors.
4tracked managers holding
2opened this quarter
0exited this quarter
Which hedge funds hold HCAT? Current holders by portfolio weight
| Manager | As of | Weight of book | Value | Shares | Δ shares | Action |
|---|---|---|---|---|---|---|
| Palogic Value Management | Q2 2026 | 3.5% | $9.8m | 4,922,442 | 70% | added |
| Renaissance Technologies LLC | Q2 2026 | 0.0% | $695.0k | 349,266 | 61% | added |
| Millennium Management | Q2 2026 | 0.0% | $1.0m | 516,083 | – | new |
| Citadel Advisors | Q2 2026 | 0.0% | $901.9k | 453,214 | – | new |
How has hedge fund ownership of HCAT changed?
| Quarter | Managers holding | Combined value |
|---|---|---|
| Q2 2026 | 4 | $12.4m |
| Q1 2026 | 2 | $4.0m |
| Q4 2025 | 2 | $4.9m |
| Q3 2025 | 3 | $4.4m |
| Q2 2025 | 2 | $3.4m |
| Q1 2025 | 2 | $3.9m |
| Q4 2024 | 2 | $3.8m |
| Q3 2024 | 2 | $5.3m |
| Q2 2024 | 4 | $3.4m |
| Q1 2024 | 5 | $24.9m |
| Q4 2023 | 4 | $45.7m |
| Q3 2023 | 6 | $57.5m |
| Q2 2023 | 7 | $55.1m |
| Q1 2023 | 7 | $42.7m |
| Q4 2022 | 8 | $35.8m |
| Q3 2022 | 7 | $34.5m |
Counts every tracked manager that disclosed HCAT in that quarter's filing, including managers that have since stopped filing.